On February 27, 2026, CMS announced a vigorous plan for anti-waste, anti-fraud measures in Medicare, with strong highlighting given to two areas: (1) durable medical equipment DME, and (2) genomic testing. The initiative, abbreviated CRUSH ("crush fraud") is open for public comment until Monday, March 30, 2026.
See my blog and links here:
https://www.discoveriesinhealthpolicy.com/2026/02/cms-issues-rfi-on-fraud-highlighting.html
Genomics fraud includes highly improper billing of hundreds of millions of dollars for genetic testing that is impossible or pointless in a Medicare population. (These occurences were vastly dominated by the states of Florida and Texas where Medicare payment controls were amazingly weak, for years.) An example of a $52M genetic test scheme is here.
There have been 183 comments to date, but comments often pour in on the final day. See the policy discussion here and find a "submit a public comment" checkbox. Anti-fraud options discussed include nationalizing MolDx.
